{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:39:56Z","timestamp":1784194796703,"version":"3.55.0"},"reference-count":61,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1128\/aac.42.6.1309","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:32:51Z","timestamp":1539045171000},"page":"1309-1314","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":76,"title":["Treatment of Infection Due to\n            <i>Pneumocystis carinii<\/i>"],"prefix":"10.1128","volume":"42","author":[{"given":"Jay Alan","family":"Fishman","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710153171602"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/jm00079a027","article-title":"Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide.","volume":"35","author":"Balkovac J. M.","year":"1992","unstructured":"Balkovac J. M. Black R. M. Hammond M. L. Heck J. V. Zambias R. A. Abruzzo G. Bartizal K. Kropp H. Trainor C. Schwartz R. E. McFadden D. C. Nollstadt K. H. Pittarelli L. A. Powles M. A. Schmatz D. M. Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. J. Med. Chem. 35 1992 194 198","journal-title":"J. Med. Chem."},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/clinids\/23.4.718","article-title":"Clindamycin\/primaquine as prophylaxis for Pneumocystis carinii pneumonia.","volume":"23","author":"Barber B. A.","year":"1996","unstructured":"Barber B. A. Pegram P. S. High K. P. Clindamycin\/primaquine as prophylaxis for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 23 1996 718 722","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.8.1834"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2436"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.4.779"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.11.3859-3862.1991"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00007611-199404000-00023","article-title":"Disseminated cryptococcal disease complicating steroid therapy for Pneumocystis carinii pneumonia in a patient with AIDS.","volume":"87","author":"Bernstein B.","year":"1987","unstructured":"Bernstein B. Flomenberg P. Letzer D. Disseminated cryptococcal disease complicating steroid therapy for Pneumocystis carinii pneumonia in a patient with AIDS. South. Med. J. 87 1987 537 538","journal-title":"South. Med. J."},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/clinids\/18.6.905","article-title":"Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS (ACTG 044).","volume":"18","author":"Black J. R.","year":"1994","unstructured":"Black J. R. Feinberg J. Murphy R. L. Fass R. J. Finkelstein D. Akil B. Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS (ACTG 044). Clin. Infect. Dis. 18 1994 905 913","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/jm00006a009","article-title":"Dicationic diarylfurans and anti-Pneumocystis carinii agents.","volume":"38","author":"Boykin D. W.","year":"1995","unstructured":"Boykin D. W. Kumar A. Spychala J. Zhou M. Lombardy R. J. Wilson W. D. Dykstra C. C. Jones S. K. Hall J. E. Tidwell R. R. Laughton C. Nunn C. M. Neidle S. Dicationic diarylfurans and anti-Pneumocystis carinii agents. J. Med. Chem. 38 1995 912 916","journal-title":"J. Med. Chem."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection.","volume":"332","author":"Bozzette S. A.","year":"1995","unstructured":"Bozzette S. A. Finkelstein D. M. Spector S. A. Frame P. Powderly W. G. He W. Phillips L. Craven D. Van der Horst C. Feinberg J. NIAID AIDS Clinical Trials Group A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 332 1995 693 699","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011223232104"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/clinids\/18.3.319","article-title":"Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia.","volume":"18","author":"Caumes E.","year":"1994","unstructured":"Caumes E. Roudier C. Rogeaux O. Bricaire F. Gentilini M. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia. Clin. Infect. Dis. 18 1994 319 323","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/j.1552-4604.1995.tb04042.x","article-title":"Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.","volume":"35","author":"Conte J. E.","year":"1995","unstructured":"Conte J. E. Jr. Golden J. A. Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. J. Clin. Pharmacol. 35 1995 1166 1173","journal-title":"J. Clin. Pharmacol."},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7326\/0003-4819-113-3-203","article-title":"Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial.","volume":"113","author":"Conte J. E.","year":"1990","unstructured":"Conte J. E. Jr. Chernoff D. Feigal D. W. Jr. Joseph P. McDonald C. Golden J. A. Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann. Intern. Med. 113 1990 203 209","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2133.1996.tb15657.x","article-title":"Employment of terbinafine against Pneumocystis carinii infection in rat models.","volume":"46","author":"Contini C.","year":"1996","unstructured":"Contini C. Colombo D. Cultrera R. Prini E. Sechi T. Angelici E. Canipari R. Employment of terbinafine against Pneumocystis carinii infection in rat models. Br. J. Dermatol. 46 1996 30 32","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.5.727"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.9.1890"},{"key":"e_1_3_1_20_2","first-page":"249","article-title":"Case records of the Massachusetts General Hospital.","volume":"332","author":"Fishman J. A.","year":"1995","unstructured":"Fishman J. A. Case records of the Massachusetts General Hospital. N. Engl. J. Med. 332 1995 249 258","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.5.995"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.7.1543"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011223232103"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1172\/JCI119326","article-title":"Neutralization of interferon-gamma exacerbates pneumocystis driven interstitial pneumonitis following bone marrow transplantation in mice.","volume":"99","author":"Garvy B. A.","year":"1997","unstructured":"Garvy B. A. Gigliotti F. Harmsen A. G. Neutralization of interferon-gamma exacerbates pneumocystis driven interstitial pneumonitis following bone marrow transplantation in mice. J. Clin. Invest. 99 1997 1637 1644","journal-title":"J. Clin. Invest."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.102.6.1730"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.7.1417"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.4.962"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/infdis\/170.4.906","article-title":"Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.","volume":"170","author":"Hughes W.","year":"1994","unstructured":"Hughes W. Killmar J. Oz H. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model. J. Infect. Dis. 170 1994 906 911","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM199305273282103","article-title":"Comparison of atovaquone (566c80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.","volume":"328","author":"Hughes W.","year":"1993","unstructured":"Hughes W. Leoung G. Kramer F. Bozzette S. A. Safrin S. Frame P. Clumeck N. Masur H. Lancaster D. Chan C. Lavelle J. Rosenstock J. Falloon J. Feinberg J. LaFon S. Rogers M. Sattler F. Comparison of atovaquone (566c80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med. 328 1993 1521 1527","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(78)80028-6"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/infdis\/171.5.1295","article-title":"Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia.","volume":"171","author":"Hughes W. T.","year":"1995","unstructured":"Hughes W. T. LaFon S. Scott J. Masur H. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. J. Infect. Dis. 171 1995 1295 1301","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.12.2661"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.2.644-650.1994"},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00007611-199004000-00010","article-title":"Clindamycin\/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.","volume":"83","author":"Kay R.","year":"1990","unstructured":"Kay R. DuBois R. E. Clindamycin\/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. South. Med. J. 83 1990 403 404","journal-title":"South. Med. J."},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/infdis\/155.5.1027","article-title":"Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.","volume":"155","author":"Kovacs J.","year":"1987","unstructured":"Kovacs J. Allegra C. Chabner B. Swan J. Drake J. Lunde M. Parrillo J. Masur H. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii. J. Infect. Dis. 155 1987 1027 1032","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7326\/0003-4819-105-1-45","article-title":"Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.","volume":"105","author":"Leoung G.","year":"1986","unstructured":"Leoung G. Mills J. Hopewell P. Hughes W. Wofsy C. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105 1986 45 48","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1164\/ajrccm\/144.4.760","article-title":"Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus.","volume":"144","author":"Levine S. J.","year":"1991","unstructured":"Levine S. J. Masur H. Gill V. J. Feuerstein I. Suffredini A. F. Brown D. Lane H. C. Yarchoan R. Shelhamer J. H. Ognibene F. P. Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Am. Rev. Respir. Dis. 144 1991 760 764","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00002030-199509000-00008","article-title":"Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia.","volume":"9","author":"Martos A.","year":"1995","unstructured":"Martos A. Podzamczer D. Martinez Lacasa J. Rufi G. Santin M. Gudiol F. Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia. AIDS 9 1995 1037 1041","journal-title":"AIDS"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-3476(95)70421-3","article-title":"Effect of corticosteroids on survival of children with acquired.","volume":"126","author":"McLaughlin G. E.","year":"1995","unstructured":"McLaughlin G. E. Virdee S. S. Schleien C. L. Holzman B. H. Scott G. B. Effect of corticosteroids on survival of children with acquired. J. Pediatr. 126 1995 821 824","journal-title":"J. Pediatr."},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.4.973"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-113-1-14","article-title":"Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS).","volume":"113","author":"Montaner J. S. G.","year":"1990","unstructured":"Montaner J. S. G. Lawson L. M. Levitt N. Belzberg A. Schecter M. T. Ruedy J. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 113 1990 14 20","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7164\/antibiotics.47.755","article-title":"Pneumocandin DO, a new antifungal agent and potent inhibitor of Pneumocystis carinii.","volume":"47","author":"Morris S. A.","year":"1994","unstructured":"Morris S. A. Schwartz R. E. Sesin D. F. Masurekar P. Hallada T. C. Schmatz D. M. Bartial K. Hensens O. D. Zink D. L. Pneumocandin DO, a new antifungal agent and potent inhibitor of Pneumocystis carinii. J. Antibiot. 47 1994 755 764","journal-title":"J. Antibiot."},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/clinids\/14.1.183","article-title":"Salvage therapy with clindamycin\/primaquine for Pneumocystis carinii pneumonia.","volume":"14","author":"Noskin G.","year":"1992","unstructured":"Noskin G. Murphy R. Black J. Phair F. Salvage therapy with clindamycin\/primaquine for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 14 1992 183 188","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/clinids\/24.5.854","article-title":"A 5-year retrospective review of adverse drug reactions and their risk factors in HIV-infected patients who were receiving intravenous therapy for Pneumocystis carinii pneumonia.","volume":"24","author":"O\u2019Brien J. G.","year":"1997","unstructured":"O\u2019Brien J. G. Dong B. J. Coleman R. L. Gee L. Balano K. B. A 5-year retrospective review of adverse drug reactions and their risk factors in HIV-infected patients who were receiving intravenous therapy for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 24 1997 854 859","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1183\/09031936.96.09030565","article-title":"Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat.","volume":"9","author":"Phelps D.","year":"1996","unstructured":"Phelps D. Umstead T. Rose R. Fishman J. A. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat. Eur. Respir. J. 9 1996 565 570","journal-title":"Eur. Respir. J."},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.10.2166"},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/clinids\/12.6.1127","article-title":"Extrapulmonary pneumocystosis: the first 50 cases.","volume":"12","author":"Raviglione M. C.","year":"1990","unstructured":"Raviglione M. C. Extrapulmonary pneumocystosis: the first 50 cases. Rev. Infect. Dis. 12 1990 1127 1138","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0922-4106(93)90023-3","article-title":"Studies on the effects of several pentamidine analogues on the NMDA receptor.","volume":"244","author":"Reynolds I. J.","year":"1993","unstructured":"Reynolds I. J. Zeleski D. M. Rothermund K. D. Hartnett K. A. Tidwell R. R. Aizenman E. Studies on the effects of several pentamidine analogues on the NMDA receptor. Eur. J. Pharmacol. 244 1993 175 179","journal-title":"Eur. J. Pharmacol."},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01964427","article-title":"Efficacy of pyrimethamine\/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.","volume":"12","author":"Ruf B.","year":"1993","unstructured":"Ruf B. Schurmann D. Bergmann F. Schuler Maue W. Grunewald T. Gottschalk W. Witt H. Pohle H. D. Efficacy of pyrimethamine\/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 12 1993 325 329","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-124-9-199605010-00003","article-title":"Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS.","volume":"124","author":"Safrin S.","year":"1996","unstructured":"Safrin S. Finkelstein D. Feinberg J. Frame P. Simpson G. Wu A. Cheung T. Soeiro R. Hojczyk P. Black J. R. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. Ann. Intern. Med. 124 1996 792 802","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/170.4.912","article-title":"Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death.","volume":"170","author":"Safrin S.","year":"1994","unstructured":"Safrin S. Lee B. Sande M. Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. J. Infect. Dis. 170 1994 912 917","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2545"},{"key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/infdis\/170.1.165","article-title":"Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029\/031.","volume":"170","author":"Sattler F.","year":"1994","unstructured":"Sattler F. ACTG 029\/031 Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029\/031. J. Infect. Dis. 170 1994 165 172","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-109-4-280","article-title":"Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective, noncrossover study.","volume":"109","author":"Sattler F. R.","year":"1988","unstructured":"Sattler F. R. Cowan R. Nielsen D. M. Ruskin J. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective, noncrossover study. Ann. Intern. Med. 109 1988 280 287","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_1_55_2","doi-asserted-by":"crossref","unstructured":"Simonds R. W. Hughes J. Feinberg and T. Navin. 1995. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 21 (Suppl. 1) : S44\u2013S48.","DOI":"10.1093\/clinids\/21.Supplement_1.S44"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.8.1713"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/clinids\/17.2.178","article-title":"Clindamycin\/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double blind pilot trial.","volume":"17","author":"Toma E.","year":"1993","unstructured":"Toma E. Fournier S. Dumont M. Bolduc P. Deschamps H. Clindamycin\/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double blind pilot trial. Clin. Infect. Dis. 17 1993 178 184","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(89)92446-X","article-title":"Clindamycin with primaquine for Pneumocystis carinii pneumonia.","author":"Toma E.","year":"1989","unstructured":"Toma E. Fournier S. Poisson M. Morisset R. Phaneuf D. Vega C. Clindamycin with primaquine for Pneumocystis carinii pneumonia. Lancet i 1989 1046 1048","journal-title":"Lancet"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/172.2.506","article-title":"Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia.","volume":"172","author":"Vargas S.","year":"1995","unstructured":"Vargas S. Hughes W. Wakefield A. Oz H. Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J. Infect. Dis. 172 1995 506 510","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2572"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-1-37"},{"key":"e_1_3_1_62_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00042560-199507000-00009","article-title":"Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia.","volume":"9","author":"White A.","year":"1995","unstructured":"White A. LaFon S. Rogers M. Andrews E. Brown N. Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9 1995 280 285","journal-title":"J. Acquired Immune Defic. Syndr. Hum. Retrovirol."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.6.1309","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.6.1309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:52:17Z","timestamp":1645458737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.42.6.1309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["10.1128\/AAC.42.6.1309"],"URL":"https:\/\/doi.org\/10.1128\/aac.42.6.1309","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]},"assertion":[{"value":"1998-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}